Literature DB >> 18528746

PRODH variants and risk for schizophrenia.

Alecia Willis1, Hans Uli Bender, Gary Steel, David Valle.   

Abstract

Schizophrenia is a common, devastating neuropsychiatric disorder whose etiology is largely unknown. Multiple studies in humans and in mouse and fly models suggest a role for proline and PRODH, the gene encoding the first enzyme in the pathway of proline catabolism, in contributing risk for schizophrenia. Other studies, however, reach contradictory conclusions. Here, we provide a critical review of the data in the context of what is known about proline metabolism and suggest studies for the future. Overall, there is considerable evidence supporting a role for certain loss of function PRODH variants conferring risk for schizophrenia in some individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18528746     DOI: 10.1007/s00726-008-0111-0

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  30 in total

Review 1.  Genome-wide approaches to schizophrenia.

Authors:  Jubao Duan; Alan R Sanders; Pablo V Gejman
Journal:  Brain Res Bull       Date:  2010-04-28       Impact factor: 4.077

Review 2.  The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders.

Authors:  Liam J Drew; Gregg W Crabtree; Sander Markx; Kimberly L Stark; Florence Chaverneff; Bin Xu; Jun Mukai; Karine Fenelon; Pei-Ken Hsu; Joseph A Gogos; Maria Karayiorgou
Journal:  Int J Dev Neurosci       Date:  2010-10-08       Impact factor: 2.457

3.  Proline metabolism and its implications for plant-environment interaction.

Authors:  Paul E Verslues; Sandeep Sharma
Journal:  Arabidopsis Book       Date:  2010-11-03

4.  Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

Authors:  Sathish Kumar Natarajan; Donald F Becker
Journal:  Cell Health Cytoskelet       Date:  2012-02-01

Review 5.  Structure, function, and mechanism of proline utilization A (PutA).

Authors:  Li-Kai Liu; Donald F Becker; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2017-07-14       Impact factor: 4.013

6.  Biophysical investigation of type A PutAs reveals a conserved core oligomeric structure.

Authors:  David A Korasick; Harkewal Singh; Travis A Pemberton; Min Luo; Richa Dhatwalia; John J Tanner
Journal:  FEBS J       Date:  2017-08-01       Impact factor: 5.542

Review 7.  Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.

Authors:  Prakash Devaraju; Stanislav S Zakharenko
Journal:  Bioessays       Date:  2017-01-03       Impact factor: 4.345

8.  Crystal structure of the bifunctional proline utilization A flavoenzyme from Bradyrhizobium japonicum.

Authors:  Dhiraj Srivastava; Jonathan P Schuermann; Tommi A White; Navasona Krishnan; Nikhilesh Sanyal; Greg L Hura; Anmin Tan; Michael T Henzl; Donald F Becker; John J Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

9.  A conserved active site tyrosine residue of proline dehydrogenase helps enforce the preference for proline over hydroxyproline as the substrate.

Authors:  Elizabeth L Ostrander; John D Larson; Jonathan P Schuermann; John J Tanner
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

10.  Crystal structures and kinetics of monofunctional proline dehydrogenase provide insight into substrate recognition and conformational changes associated with flavin reduction and product release.

Authors:  Min Luo; Benjamin W Arentson; Dhiraj Srivastava; Donald F Becker; John J Tanner
Journal:  Biochemistry       Date:  2012-12-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.